Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

for
Bladder Cancer, Urinary Bladder Neoplasm, Urologic Neoplasms,
Location: Boston MA, Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT04442724

Recruiting

Expressive Writing for the Management of Stress in Cancer Survivors

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04776941

Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Providence RI, New York NY, Miami Beach FL,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase 2, Recruiting

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

for
Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia,
Location: Duluth MN, Virginia MN, Rochester MN, Hibbing MN,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06395441

Phase 3, Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05536141

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

for
Brain Tumor, Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 15 - 70+

Code: NCT05588141

Phase 1, Phase 2, Recruiting

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

for
Pediatric Cancer
Location: Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 2 - 21

Code: NCT04948619

Phase 2, Recruiting

Long-Term Follow-Up of Recipient of Gene Transfer Research

for
Retroviridae Infections, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT01492036

Recruiting

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 21+

Code: NCT05054413

Recruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

for
End of Life, Cancer
Location: Birmingham AL, Mobile AL, Salt Lake City UT, Duarte CA,
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05297734

Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Charlottesville VA, Detroit MI, Indianapolis IN,
Sponsor: Vijendra Singh

Sex: All

Age: 18+

Code: NCT05852717

Phase 2, Recruiting

Evaluating Disparities in Precision Oncology

for
Metastatic Cancer, Advanced Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06081517

Recruiting

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer

for
Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 20 - 70+

Code: NCT06083324

Recruiting

Study of Biomarkers in Gynecological Cancers

for
Gynecologic Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03420118

Recruiting

CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth

for
Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT05405413

Phase 2, Recruiting

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

for
Pediatric Cancer
Location: Chicago IL
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: All

Age: 0+

Code: NCT05120518

Recruiting

Definitive Radiation for High-Risk Spine Metastases

for
Metastatic Cancer, Metastatic Lung Cancer,
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: All

Age: 18+

Code: NCT06165419

Recruiting

Galleri® in the Medicare Population.

for
Cancer
Location: Rockledge PA, Philadelphia PA, Furlong PA,
Sponsor: GRAIL, Inc.

Sex: All

Age: 50+

Code: NCT05673018

Recruiting

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

for
Cancer Patients, Care Givers
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 40+

Code: NCT06305741

Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

for
Locally Advanced Unresectable or Metastatic Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT05458219

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial